Literature DB >> 27497366

Transcatheter closure of atrial septal defects without fluoroscopy: a well-established procedure for alternative use in children.

Yifeng Yang1, Weizhi Zhang, Qin Wu, Lei Gao, Wancun Jin, Tianli Zhao.   

Abstract

AIMS: The feasibility of transcatheter closure of atrial septal defects (ASD) without fluoroscopy has been proven. However, the technique has not been accepted for routine use. We report our experience with trans-catheter closure of ASD without fluoroscopy and introduce a well-established technique for alternative use in children. METHODS AND
RESULTS: From November 2013 to May 2015, a total of 114 children with isolated secundum ASD (diameter 6 mm to 24 mm, median 13.8 mm) underwent attempted transcatheter device closure under the guidance of transoesophageal echocardiography without fluoroscopy. Using a modified delivery system and procedure technique, ASD were successfully closed in 110 patients (96.5%, 52 males, 58 females, aged from three to 14 years, median 5.4 years, weight 12 to 46 kg, median 23.5 kg). Procedure time ranged from eight to 42 minutes (median 18 min). Three patients underwent percardiac device closure after failed procedures. In the early stage of our study, before delivery system and technique modification, one patient was converted to open heart surgery due to rupture of the left appendage. No intervention-related complications were detected during a median follow-up of nine months.
CONCLUSIONS: Using a modified delivery system and a re-established procedure, we showed that transcatheter closure of ASD without fluoroscopy is a safe technique for alternative use in children.

Entities:  

Mesh:

Year:  2016        PMID: 27497366     DOI: 10.4244/EIJV12I5A106

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  8 in total

Review 1.  Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease.

Authors:  Abhay A Divekar; Yousef M Arar; Stephen Clark; Animesh Tandon; Thomas M Zellers; Surendranath R Veeram Reddy
Journal:  Children (Basel)       Date:  2022-04-02

Review 2.  Pregnancy in adults with repaired/unrepaired atrial septal defect.

Authors:  Charlène Bredy; François-Pierre Mongeon; Line Leduc; Annie Dore; Paul Khairy
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Transcatheter device closure of atrial septal defects guided completely by transthoracic echocardiography: A single cardiac center experience with 152 cases.

Authors:  Qiang Chen; Hua Cao; Gui Can Zhang; Liang Wan Chen; Heng Lu; Lin Li Yu
Journal:  Anatol J Cardiol       Date:  2018-12       Impact factor: 1.596

4.  Transcatheter Atrial Septal Defect Closure in Children with and without Fluoroscopy: A Comparison.

Authors:  S Ackermann; D Quandt; N Hagenbuch; O Niesse; M Christmann; W Knirsch; O Kretschmar
Journal:  J Interv Cardiol       Date:  2019-04-07       Impact factor: 2.279

5.  Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.

Authors:  Yangyang Han; Xiquan Zhang; Fengwei Zhang
Journal:  J Cardiothorac Surg       Date:  2020-01-09       Impact factor: 1.637

6.  The M310T mutation in the GATA4 gene is a novel pathogenic target of the familial atrial septal defect.

Authors:  Haisong Bu; Guowen Sun; Yun Zhu; Yifeng Yang; Zhiping Tan; Tianli Zhao; Shijun Hu
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298

7.  Non-fluoroscopic percutaneous transcatheter closure of atrial septal defects in children under transesophageal echocardiographic guidance.

Authors:  Wei-Ze Xu; Xin-Yi Shou; Jian-Hua Li; Jian-Gen Yu; Ze-Wei Zhang; Jin Yu; Jing-Jing Ye
Journal:  World J Pediatr       Date:  2018-08-15       Impact factor: 2.764

8.  Echocardiography-guided percutaneous closure of perimembranous ventricular septal defects without arterial access and fluoroscopy.

Authors:  Haisong Bu; Yifeng Yang; Qin Wu; Wancun Jin; Tianli Zhao
Journal:  BMC Pediatr       Date:  2019-08-31       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.